IRIDEXIRIX +1.28%66 Forward Dividend Yield % is 0.00% as of Jun. 25, 2026. GuruFocus rates IRIX with a GF Score™ of 66/100 and a GF Value™ of $1.70 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 316 Medical Devices & Instruments companies, IRIDEX ranks worse than 316455.38% on this metric.
As of today (2026-06-25), the Forward Annual Dividend Yield of IRIDEX is 0.00%.
As of today (2026-06-25), the Trailing Annual Dividend Yield of IRIDEX is 0.00%.
IRIX's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.045 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
IRIX vs ICCM, ADGM, CSDX: Forward Dividend Yield % Comparison
For the Medical Devices subindustry, IRIDEX's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IRIDEX Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IRIDEX's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where IRIDEX's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
IRIDEX (IRIX) has a Forward Dividend Yield % of 0.00% as of Jun. 25, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on IRIDEX and its competitors. According to the industry distribution chart, IRIDEX ranks #999999 out of 316 companies in the Medical Devices & Instruments industry.
Is IRIDEX's Forward Dividend Yield % too high?
IRIDEX's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, IRIDEX ranks #999999 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, IRIDEX has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IRIDEX's Forward Dividend Yield % compare to ICCM and ADGM?
According to the Medical Devices & Instruments industry distribution chart, IRIDEX ranks #999999 out of 316 companies for Forward Dividend Yield %. This places IRIDEX in the lower half of its industry. The industry median Forward Dividend Yield % is 2.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.05, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on IRIDEX and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IRIDEX's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IRIDEX stock overvalued right now?
Based on GuruFocus' analysis, IRIDEX (IRIX) is currently considered Possible Value Trap. The stock's GF Value™ is $1.70, compared to a current price of $1.19 — trading 30% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. IRIDEX's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For IRIDEX (IRIX), the current Forward Dividend Yield % is 0.00% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IRIDEX (IRIX) Overvalued in 2026?
Based on GuruFocus' analysis, IRIDEX stock appears to be undervalued.
The current stock price of $1.19 is trading 30% below its estimated GF Value™ of $1.70.
GuruFocus considers IRIDEX to be Possible Value Trap.
Key valuation signals for IRIX:
Forward Dividend Yield %: 0.00%
GF Value™: $1.70 vs. price of $1.19 (30% below fair value)
No single metric tells the full story. See the IRIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
66GF Score
Get the complete analysis for IRIX
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRIX has been successfully added to your 